Table 2.
N | % | |
---|---|---|
Subjective sleep quality | ||
No-risk group (= 0) | 182 | 30.9 |
Risk group (≥ 1) | 407 | 69.1 |
Sleep latency | ||
No-risk group (= 0) | 325 | 56.3 |
Risk group (≥ 1) | 252 | 43.7 |
Sleep duration | ||
No-risk group (= 0) | 540 | 91.4 |
Risk group (≥ 1) | 51 | 8.6 |
Habitual sleep efficiency | ||
No-risk group (= 0) | 567 | 98.1 |
Risk group (≥ 1) | 11 | 1.9 |
Sleep disturbances | ||
No-risk group (= 0) | 313 | 53.6 |
Risk group (≥ 1) | 271 | 46.4 |
Use of sleeping medication | ||
No-risk group (= 0) | 591 | 99.3 |
Risk group (≥ 1) | 4 | 0.7 |
Daytime dysfunction | ||
No-risk group (= 0) | 305 | 53.4 |
Risk group (≥ 1) | 266 | 46.6 |
PSQI-global score | ||
No-risk group (≤ 5) | 499 | 94.5 |
Risk group (> 5) | 29 | 5.5 |
Behavioral problems | ||
No-risk group (< 17) | 565 | 93.5 |
Risk group (≥ 17) | 39 | 6.5 |
PSQI, Pittsburgh Sleep Quality Index; Sleep Disorder; PSQI-global score > 5; Strength and Difficulties Questionnaire; total difficulties score ≥ 17